GHRP-1 vs LL-37 Truncated Variants (KR-12 / KS-30)
First-generation growth hormone-releasing hexapeptide; precursor to GHRP-2/-6. versus Shorter active fragments of LL-37 (KR-12, KS-30) with retained antimicrobial activity but lower toxicity.
GHRP-1
PerformanceFirst-generation growth hormone-releasing hexapeptide; precursor to GHRP-2/-6.
Top benefits
- ✓Stimulates pituitary GH release
- ✓Synergizes with GHRH analogs
- ✓Lean mass support
LL-37 Truncated Variants (KR-12 / KS-30)
RecoveryShorter active fragments of LL-37 (KR-12, KS-30) with retained antimicrobial activity but lower toxicity.
Top benefits
- ✓Antimicrobial activity preserved
- ✓Lower hemolysis vs full LL-37
- ✓Wound healing research
| Attribute | GHRP-1 | LL-37 Truncated Variants (KR-12 / KS-30) |
|---|---|---|
| Category | Performance | Recovery |
| Type | linear | linear |
| Chain length | 7 aa | 12 aa |
| Formula | C46H56N12O6 | KR-12 fragment of LL-37 |
| Common dose | 100-300 mcg | Not established |
| Frequency | 1-3x daily | N/A |
| Top benefit | Stimulates pituitary GH release | Antimicrobial activity preserved |
| Top side-effect | Mild cortisol/prolactin rise | Localized irritation (topical) |
Educational use only
This calculator is provided for research and educational purposes. Outputs are derived from the values you enter. Always verify your math and consult a licensed physician before acting on any result.